Comparison between Accretion Pharmaceuticals IPO and Moving Media Entertainment IPO.
Accretion Pharmaceuticals IPO is a SME Bookbuilding IPO proposed to list at NSE SME while Moving Media Entertainment IPO is a SME Bookbuilding proposed to list at NSE SME.
| Accretion Pharmaceuticals IPO | Moving Media Entertainment IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Bookbuilding | Bookbuilding |
| Listing At | NSE SME | NSE SME |
| Lead Managers | Jawa Capital Services Pvt.Ltd. | Gretex Corporate Services Ltd. |
| Registrar | Kfin Technologies Ltd. | Maashitla Securities Pvt.Ltd. |
| Market Maker | Gretex Share Broking Pvt.Ltd. | Gretex Share Broking Pvt.Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Anchor Investor | Anchor Investor | Anchor Investor |
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Accretion Pharmaceuticals IPO is up to ₹28.26 Cr whereas the issue size of the Moving Media Entertainment IPO is up to ₹32.91 Cr. The final issue price of Accretion Pharmaceuticals IPO is ₹101.00 per share and of Moving Media Entertainment IPO is ₹70.00 per share.
| Accretion Pharmaceuticals IPO | Moving Media Entertainment IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹96.00 per share | ₹66.00 per share |
| Issue Price (Upper) | ₹101.00 per share | ₹70.00 per share |
| Issue Price (Final) | ₹101.00 per share | ₹70.00 per share |
| Discount (Retail) | ₹0.00 per share | |
| Discount (Employee) | ||
| Market Lot Size | 1200 shares | 2000 shares |
| Fresh Issue Size | 27,98,400 shares | 47,02,000 shares |
| Fresh Issue Size (Amount) | up to ₹28.26 Cr | up to ₹32.91 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 27,98,400 shares | 47,02,000 shares |
| Issue Size Total (Amount) | up to ₹28.26 Cr | up to ₹32.91 Cr |
Accretion Pharmaceuticals IPO opens on May 14, 2025, while Moving Media Entertainment IPO opens on Jun 26, 2025. The closing date of Accretion Pharmaceuticals IPO and Moving Media Entertainment IPO is May 16, 2025, and Jun 30, 2025, respectively.
| Accretion Pharmaceuticals IPO | Moving Media Entertainment IPO | |
|---|---|---|
| Anchor Bid Date | May 13, 2025 | Jun 25, 2025 |
| Issue Open | May 14, 2025 | Jun 26, 2025 |
| Issue Close | May 16, 2025 | Jun 30, 2025 |
| Basis Of Allotment (Tentative) | May 19, 2025 | Jul 01, 2025 |
| Initiation of Refunds (Tentative) | May 20, 2025 | Jul 02, 2025 |
| Credit of Share (Tentative) | May 20, 2025 | Jul 02, 2025 |
| Listing date (Tentative) | May 21, 2025 | Jul 03, 2025 |
| Anchor Lockin End date 1 | Jun 18, 2025 | Jul 31, 2025 |
| Anchor Lockin End date 2 | Aug 17, 2025 | Sep 29, 2025 |
Accretion Pharmaceuticals IPO P/E ratio is 21.29, as compared to Moving Media Entertainment IPO P/E ratio of 8.49.
| Accretion Pharmaceuticals IPO | Moving Media Entertainment IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Accretion Pharmaceuticals Limited Financial Information (Restated Consolidated)
| Moving Media Entertainment Limited Financial Information (Restated)Moving Media Entertainment Limited's revenue increased by 59% and profit after tax (PAT) rose by 3% between the financial year ending with March 31, 2025 and March 31, 2024.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 100.00 | 85.58 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 73.48 | 57.36 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 21.29 | 8.49 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹112.27 Cr. | ₹131.64 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 72.47% | 26.35% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 36.73% | 18.49% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 2.52 | 1.05 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹4.74 | ₹8.25 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 72.47% | 26.35% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Accretion Pharmaceuticals IPO Retail Individual Investors (RII) are offered 12,22,800 shares while in Moving Media Entertainment IPO retail investors are offered 12,22,800 shares. Qualified Institutional Buyers (QIB) are offered 1,41,600 shares in Accretion Pharmaceuticals IPO and 9,40,000 shares in Moving Media Entertainment IPO.
| Accretion Pharmaceuticals IPO | Moving Media Entertainment IPO | |
|---|---|---|
| Anchor Investor Reserveration | 2,11,200 shares | 14,10,000 shares |
| Market Maker Reserveration | 1,47,600 shares | 14,98,000 shares |
| QIB | 1,41,600 shares | 9,40,000 shares |
| NII | 12,22,800 shares | 7,06,000 shares |
| RII | 12,22,800 shares | 16,46,000 shares |
| Employee | 0 shares | 0 shares |
| Others | ||
| Total | 27,98,400 shares | 47,02,000 shares |
Accretion Pharmaceuticals IPO subscribed 7.67x in total, whereas Moving Media Entertainment IPO subscribed 73.40x.
| Accretion Pharmaceuticals IPO | Moving Media Entertainment IPO | |
|---|---|---|
| QIB (times) | 12.14x | 55.23x |
| NII (times) | 4.28x | 126.07x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 10.54x | 61.18x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 7.67x | 73.40x |
Free Equity Delivery
Flat ₹10 per Trade in Intraday & F&O
